‘Failure-to-Update’ Claims Preempted in Generic Reglan Case, La. Federal Judge Rules



DOCUMENTS
  • Order


BATON ROUGE, La. — Claims that the makers of generic Reglan failed to update their labels to incorporate additional FDA-approved warnings are federally preempted under Morris v. PLIVA Inc., a Louisiana federal judge has ruled upon a motion for reconsideration by the drug makers.

On Dec. 11, Judge Shelly D. Dick of the U.S. District Court for the Middle District of Louisiana explained that federal law prohibited the generic defendants from incorporating the additional changes unilaterally.

In May 1998, Robert Cooper was prescribed Reglan to treat his acid reflux; his prescription was filled with the drug’s generic equivalent, metoclopramide. In …

FIRM NAMES
  • Barrasso Usdin Kupperman Freeman & Sarver
  • Curtis Law Group
  • Law Offices of Steven Gill
  • McGlynn Glisson & Mouton
  • Ulmer & Berne





UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS